202 related articles for article (PubMed ID: 22725618)
21. Efficacy and safety of pregabalin in the treatment of alcohol and benzodiazepine dependence.
Oulis P; Konstantakopoulos G
Expert Opin Investig Drugs; 2012 Jul; 21(7):1019-29. PubMed ID: 22568872
[TBL] [Abstract][Full Text] [Related]
22. [Pregabalin for the reduction of opiate withdrawal symptoms].
Kämmerer N; Lemenager T; Grosshans M; Kiefer F; Hermann D
Psychiatr Prax; 2012 Oct; 39(7):351-2. PubMed ID: 22689280
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of pregabalin in the treatment of alcohol withdrawal syndrome: a randomized placebo-controlled trial.
Förg A; Hein J; Volkmar K; Winter M; Richter C; Heinz A; Müller CA
Alcohol Alcohol; 2012; 47(2):149-55. PubMed ID: 22215002
[TBL] [Abstract][Full Text] [Related]
24. Pregabalin for alcohol dependence: a critical review of the literature.
Guglielmo R; Martinotti G; Clerici M; Janiri L
Adv Ther; 2012 Nov; 29(11):947-57. PubMed ID: 23132700
[TBL] [Abstract][Full Text] [Related]
25. [New molecular targets in pharmacological treatment of anxiety disorders].
Barenbaum RD; Rilla Manta L
Vertex; 2004; 15 Suppl 1():5-11. PubMed ID: 15505688
[TBL] [Abstract][Full Text] [Related]
26. Pregabalin: a novel gamma-aminobutyric acid analogue in the treatment of neuropathic pain, partial-onset seizures, and anxiety disorders.
Tassone DM; Boyce E; Guyer J; Nuzum D
Clin Ther; 2007 Jan; 29(1):26-48. PubMed ID: 17379045
[TBL] [Abstract][Full Text] [Related]
27. Elucidating the mechanism of action of pregabalin: α(2)δ as a therapeutic target in anxiety.
Micó JA; Prieto R
CNS Drugs; 2012 Aug; 26(8):637-48. PubMed ID: 22784017
[TBL] [Abstract][Full Text] [Related]
28. Tolerability and use in co-administration of pregabalin in affective patients: a 6-month prospective naturalistic study.
Dobrea C; Buoli M; Arici C; Camuri G; Dell'Osso B; Altamura AC
Expert Opin Drug Saf; 2012 Nov; 11(6):893-9. PubMed ID: 22946673
[TBL] [Abstract][Full Text] [Related]
29. [Pregabalin--a neuromodulator for the treatment of neuropathic pain, generalized anxiety disorders and fibromyalgia syndrome].
Nymdelger S; Nieber K
Med Monatsschr Pharm; 2007 Nov; 30(11):396-400. PubMed ID: 18062330
[TBL] [Abstract][Full Text] [Related]
30. Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial.
Richter RW; Portenoy R; Sharma U; Lamoreaux L; Bockbrader H; Knapp LE
J Pain; 2005 Apr; 6(4):253-60. PubMed ID: 15820913
[TBL] [Abstract][Full Text] [Related]
31. Pregabalin: as adjunctive treatment of partial seizures.
Warner G; Figgitt DP
CNS Drugs; 2005; 19(3):265-72; discussion 273-4. PubMed ID: 15740180
[TBL] [Abstract][Full Text] [Related]
32. Pregabalin abuse, dependence, and withdrawal: a case report.
Grosshans M; Mutschler J; Hermann D; Klein O; Dressing H; Kiefer F; Mann K
Am J Psychiatry; 2010 Jul; 167(7):869. PubMed ID: 20595436
[No Abstract] [Full Text] [Related]
33. Effects of pregabalin on subjective sleep disturbance symptoms during withdrawal from long-term benzodiazepine use.
Rubio G; Bobes J; Cervera G; Terán A; Pérez M; López-Gómez V; Rejas J
Eur Addict Res; 2011; 17(5):262-70. PubMed ID: 21701173
[TBL] [Abstract][Full Text] [Related]
34. Calcium channel alpha2-delta type 1 subunit is the major binding protein for pregabalin in neocortex, hippocampus, amygdala, and spinal cord: an ex vivo autoradiographic study in alpha2-delta type 1 genetically modified mice.
Bian F; Li Z; Offord J; Davis MD; McCormick J; Taylor CP; Walker LC
Brain Res; 2006 Feb; 1075(1):68-80. PubMed ID: 16460711
[TBL] [Abstract][Full Text] [Related]
35. Pregabalin for the treatment of generalized anxiety disorder: a novel pharmacologic intervention.
Bandelow B; Wedekind D; Leon T
Expert Rev Neurother; 2007 Jul; 7(7):769-81. PubMed ID: 17610384
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and tolerability of pregabalin in partial epilepsy.
Beydoun A; Nasreddine W; Atweh S
Expert Rev Neurother; 2008 Jul; 8(7):1013-24. PubMed ID: 18590472
[TBL] [Abstract][Full Text] [Related]
37. [Pregabalin--a drug with abuse potential?].
Skopp G; Zimmer G
Arch Kriminol; 2012; 229(1-2):44-54. PubMed ID: 22448469
[TBL] [Abstract][Full Text] [Related]
38. [Generalized anxiety disorder with comorbidity. Treatment with pregabalin].
Lauer D; Hölzel L; Hornyak M
Nervenarzt; 2006 Nov; 77(11):1363, 1365-7. PubMed ID: 16786360
[TBL] [Abstract][Full Text] [Related]
39. Potential for pregabalin abuse or diversion after past drug-seeking behavior.
Filipetto FA; Zipp CP; Coren JS
J Am Osteopath Assoc; 2010 Oct; 110(10):605-7. PubMed ID: 21068226
[TBL] [Abstract][Full Text] [Related]
40. Switching from long-term benzodiazepine therapy to pregabalin in patients with generalized anxiety disorder: a double-blind, placebo-controlled trial.
Hadley SJ; Mandel FS; Schweizer E
J Psychopharmacol; 2012 Apr; 26(4):461-70. PubMed ID: 21693549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
